These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21233209)

  • 1. Cyclin-cyclin-dependent kinase regulatory response is linked to substrate recognition.
    Cuomo ME; Platt GM; Pearl LH; Mittnacht S
    J Biol Chem; 2011 Mar; 286(11):9713-25. PubMed ID: 21233209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two maize Kip-related proteins differentially interact with, inhibit and are phosphorylated by cyclin D-cyclin-dependent kinase complexes.
    Godínez-Palma SK; Rosas-Bringas FR; Rosas-Bringas OG; García-Ramírez E; Zamora-Zaragoza J; Vázquez-Ramos JM
    J Exp Bot; 2017 Mar; 68(7):1585-1597. PubMed ID: 28369656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
    Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
    EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
    Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
    J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Swanton C; Mann DJ; Fleckenstein B; Neipel F; Peters G; Jones N
    Nature; 1997 Nov; 390(6656):184-7. PubMed ID: 9367157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity.
    Kaldis P
    J Biol Chem; 2005 Mar; 280(12):11165-74. PubMed ID: 15664993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD; Tong L; Pavletich NP
    Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.
    Li M; Lee H; Yoon DW; Albrecht JC; Fleckenstein B; Neipel F; Jung JU
    J Virol; 1997 Mar; 71(3):1984-91. PubMed ID: 9032330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular systems biology of Sic1 in yeast cell cycle regulation through multiscale modeling.
    Barberis M
    Adv Exp Med Biol; 2012; 736():135-67. PubMed ID: 22161326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in cyclin-dependent kinase biochemical and structural studies.
    Echalier A; Endicott JA; Noble ME
    Biochim Biophys Acta; 2010 Mar; 1804(3):511-9. PubMed ID: 19822225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinases: inhibition and substrate recognition.
    Endicott JA; Noble ME; Tucker JA
    Curr Opin Struct Biol; 1999 Dec; 9(6):738-44. PubMed ID: 10607671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New functional activities for the p21 family of CDK inhibitors.
    LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
    Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.